Keyword: Johnson & Johnson
Markets & Companies
13.03.2015
- Both European and US pharmaceutical industry players are highly research-oriented and possess very diversified portfolios. While each country has its national champions, Swiss...
News
27.02.2015
- The Supreme Court of the US state of South Carolina has ordered Johnson & Johnson to pay a penalty of $136 million, upholding a jury's finding that the drugmaker's Janssen unit had...
News
04.02.2015
- The venture capital arms of two international drugmakers in late January participated in a $20 million Atlas fund-raising initiative to benefit the development of a new quick...
News
07.01.2015
- US over-the-counter drugmaker Johnson & Johnson will pay Isis Pharmaceuticals up to $835 million for the option to license three drugs targeting autoimmune diseases in the bowel...
News
23.12.2014
- The largest pharmacy benefit manager in the US, Express Scripts, has negotiated a cheaper price from AbbVie for its Viekira Pak hepatitis C treatment approved by the US Food and...
News
16.10.2014
- Bayer soon may find itself regretting its decision to sell its plastics business and become a pure life science player. According to international press reports, the German group's...
News
18.08.2014
- Codexis, a developer of biocatalysts for the pharmaceutical and fine chemical industries, announced that Gordon Sangster has agreed to join Codexis as Senior Vice President & Chief...
News
17.07.2014
- Swiss drugmaker Roche said its experimental Alzheimer's drug failed to meet its main goals in a mid-stage study, a result likely to bolster the belief that drugs need to be given...
